Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa

Trial Profile

Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jul 2014

At a glance

  • Drugs Pramipexole (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Sponsors Boehringer Ingelheim Pharmaceuticals
  • Most Recent Events

    • 15 Jan 2010 Actual end date (September 2009) added as reported by ClinicalTrials.gov.
    • 01 Jan 2010 Planned end date changed from 1 Aug 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov.
    • 04 Nov 2009 Actual patient number (416) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top